Contact this trialFirst, we need to learn more about you.
Central Nervous System Depressant
Sodium Oxybate for Voice Disorders
Recruiting1 awardPhase 2 & 3
Boston, Massachusetts
This trial tests if sodium oxybate, an oral medication, can improve voice symptoms in patients with spasmodic dysphonia and voice tremor by affecting brain mechanisms. Sodium oxybate has shown significant improvement in voice symptoms for patients with spasmodic dysphonia and voice tremor in previous studies.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service